Molecules, Materials, Medicines (M3): Linking Molecules to Medicines through Pharmaceutical Material Science

被引：13

作者：

Almarsson, Oern ^{[1
]}

Vadas, Elizabeth B. ^{[2
]}

机构：

[1] Moderna Therapeut Inc, Cambridge, MA 02139 USA

[2] InSciTech Inc, Dorval, PQ, Canada

来源：

CRYSTAL GROWTH & DESIGN | 2015年 / 15卷 / 12期

关键词：

D O I：

10.1021/acs.cgd.5b01417

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

[No abstract available]

引用

页码：5645 / 5647

页数：3

共 12 条

[1] Crystal engineering of the composition of pharmaceutical phases.: Do pharmaceutical co-crystals represent a new path to improved medicines? [J].

Almarsson, Ö ;

Zaworotko, MJ .

CHEMICAL COMMUNICATIONS, 2004, (17) :1889-1896

[2] The co-crystal approach to improve the exposure of a water-insoluble compound: AMG 517 sorbic acid co-crystal characterization and pharmacokinetics [J].

Bak, Annette ;

Gore, Anu ;

Yanez, Evelyn ;

Stanton, Mary ;

Tufekcic, Sunita ;

Syed, Rashid ;

Akrami, Anna ;

Rose, Mark ;

Surapaneni, Sekhar ;

Bostick, Tracy ;

King, Anthony ;

Neervannan, Sesha ;

Ostovic, Drazen ;

Koparkar, Arun .

JOURNAL OF PHARMACEUTICAL SCIENCES, 2008, 97 (09) :3942-3956

[3] Development of an Early-Phase Bulk Enabling Route to Sodium-Dependent Glucose Cotransporter 2 Inhibitor Ertugliflozin [J].

Bernhardson, David ;

Brandt, Thomas A. ;

Hulford, Catherine A. ;

Lehner, Richard S. ;

Preston, Brian R. ;

Price, Kristin ;

Sagal, John F. ;

St Pierre, Michael J. ;

Thompson, Peter H. ;

Thuma, Benjamin .

ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2014, 18 (01) :57-65

[4] Assessment of the physical stability of lyophilized MK-0591 by differential scanning calorimetry [J].

Clas, SD ;

Cotton, M ;

Moran, E ;

Spagnoli, S ;

Zografi, G ;

Vadas, EB .

THERMOCHIMICA ACTA, 1996, 288 (1-2) :83-96

[5] The potency-insolubility conundrum in pharmaceuticals: Mechanism and solution for hepatitis C protease inhibitors [J].

Connelly, Patrick R. ;

Snyder, Phillip W. ;

Zhang, Yuegang ;

McClain, Brian ;

Quinn, Brian P. ;

Johnston, Steve ;

Medek, Ales ;

Tanoury, Jerry ;

Griffith, James ;

Walters, W. Patrick ;

Dokou, Eleni ;

Knezic, Dragutin ;

Bransford, Philip .

BIOPHYSICAL CHEMISTRY, 2015, 196 :100-108

[6] Downstream processing of polymer-based amorphous solid dispersions to generate tablet formulations [J].

Demuth, B. ;

Nagy, Z. K. ;

Balogh, A. ;

Vigh, T. ;

Marosi, G. ;

Verreck, G. ;

Van Assche, I. ;

Brewster, M. E. .

INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2015, 486 (1-2) :268-286

[7] Cyclodextrins as functional excipients: Methods to enhance complexation efficiency [J].

Loftsson, Thorsteinn ;

Brewster, Marcus E. .

JOURNAL OF PHARMACEUTICAL SCIENCES, 2012, 101 (09) :3019-3032

[8] On the importance of synthetic organic chemistry in drug discovery: reflections on the discovery of antidiabetic agent ertugliflozin [J].

Mascitti, Vincent ;

Thuma, Benjamin A. ;

Smith, Aaron C. ;

Robinson, Ralph P. ;

Brandt, Thomas ;

Kalgutkar, Amit S. ;

Maurer, Tristan S. ;

Samas, Brian ;

Sharma, Raman .

MEDCHEMCOMM, 2013, 4 (01) :101-111

[9] Glass-Liquid Phase Separation in Highly Supersaturated Aqueous Solutions of Telaprevir [J].

Mosquera-Giraldo, Laura I. ;

Taylor, Lynne S. .

MOLECULAR PHARMACEUTICS, 2015, 12 (02) :496-503

[10] Assessing the performance of amorphous solid dispersions [J].

Newman, Ann ;

Knipp, Gregory ;

Zografi, George .

JOURNAL OF PHARMACEUTICAL SCIENCES, 2012, 101 (04) :1355-1377

← 1 2 →